PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Vincent Picozzi

Virginia Mason Medical Center, Seattle, Washington, USA.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 28, 2026 · JOURNAL ARTICLE

Estimating the cost-effectiveness of tumor treating fields for locally advanced pancreatic cancer patients.

Journal of Medical Economics

Cost-utility analysis of a novel cancer therapy showing incremental QALY gain with high ICER; confirms clinical benefit translates to measurable quality-of-life improvement but at costs above conventional thresholds.

Important Confirmatory EvidenceJorge Fernando Niño de Rivera Guzman Gregory F Guzauskas Locally Advanced Pancreatic Cancer

Reported

Lifetime cost TTFields + GnP$351,400

Lifetime cost GnP alone$220,000

Incremental QALYs0.34

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support